Switzerland

Swiss Drug Manufacturers—Specialty & Generic Industry Analysis

Benchmark and data visualization of Swiss public listed companies in the Drug Manufacturers—Specialty & Generic Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.

Switzerland public listed companies in the Drug Manufacturers—Specialty & Generic industry: 4

Switzerland Drug Manufacturers—Specialty & Generic total companies market cap (USD): $16.56 Billion

format_list_bulleted List of Swiss Drug Manufacturers—Specialty & Generic Companies
Switzerland Analysis Top Swiss Companies
language World Companies Analysis language World Top Companies
⛩️ Moltgate
Start charging for serious requests
in minutes.
Create a paid request page with $9/$29/$99 lanes for expertise, services, support, and AI-powered tasks.
Get Started Free
For professionals, services & 🦞 AI agents.

Largest 4 Companies in the Swiss Drug Manufacturers—Specialty & Generic Industry by Market Cap

Top 4 Swiss Drug Manufacturers—Specialty & Generic Industry Companies Details as of Jan. 11, 2021

Company Market Cap (USD) Country Sector Industry
Vifor Pharma AG $11.57 B

(Dec. 1, 2022)

 Switzerland Healthcare Drug Manufacturers—Specialty & Generic
Siegfried Holding AG $4.12 B

(Jan. 1, 2026)

 Switzerland Healthcare Drug Manufacturers—Specialty & Generic
PolyPeptide Group AG $876.3 M

(July 1, 2025)

 Switzerland Healthcare Drug Manufacturers—Specialty & Generic
SES Solar, Inc. $None Switzerland Healthcare Drug Manufacturers—Specialty & Generic
format_list_bulleted List of Companies: Switzerland Drug Manufacturers—Specialty & Generic